Seshadri Neervannan

Insider Reports History

Location
Irvine, CA
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seshadri Neervannan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Common Stock 79.2K $5.92M $74.81 16 Dec 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Restricted Stock Units 24.1K $310K $12.89 15 Mar 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Common Stock 475 $35.5K $74.81 16 Dec 2025 By daughter
Tarsus Pharmaceuticals, Inc. Chief Operating Officer Stock Option (right to buy) 30.6K 05 Mar 2025 Direct

Insider Reports Filed by Seshadri Neervannan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 16 Dec 2025 2 $0 4 Chief Operating Officer 18 Dec 2025, 16:09
TARS Tarsus Pharmaceuticals, Inc. 18 Mar 2025 3 -$363K 4 Chief Operating Officer 20 Mar 2025, 21:49
TARS Tarsus Pharmaceuticals, Inc. 15 Mar 2025 4 $0 4 Chief Operating Officer 18 Mar 2025, 21:39
TARS Tarsus Pharmaceuticals, Inc. 05 Mar 2025 2 $0 4 Chief Operating Officer 07 Mar 2025, 16:19
TARS Tarsus Pharmaceuticals, Inc. 15 Mar 2024 4 -$149K 4 Chief Operating Officer 19 Mar 2024, 19:03
TARS Tarsus Pharmaceuticals, Inc. 07 Mar 2024 2 $0 4 Chief Operating Officer 11 Mar 2024, 17:10
TARS Tarsus Pharmaceuticals, Inc. 21 Mar 2023 3 -$14.3K 4 Chief Operating Officer 23 Mar 2023, 19:56
TARS Tarsus Pharmaceuticals, Inc. 17 Mar 2023 2 -$9.57K 4 Chief Operating Officer 21 Mar 2023, 19:12
TARS Tarsus Pharmaceuticals, Inc. 15 Mar 2023 3 -$4.79K 4 Chief Operating Officer 17 Mar 2023, 18:15
TARS Tarsus Pharmaceuticals, Inc. 08 Mar 2023 2 $0 4 Chief Operating Officer 10 Mar 2023, 18:26
TARS Tarsus Pharmaceuticals, Inc. 09 Mar 2022 2 $0 4 Chief Operating Officer 11 Mar 2022, 15:17